Open this publication in new window or tab >>Show others...
2010 (English)In: Molecular Medicine, ISSN 1076-1551, E-ISSN 1528-3658, Vol. 16, no 07-Aug, p. 235-246Article in journal (Refereed) Published
Abstract [en]
The protein kinase mammalian target of rapamycin (mTOR) mediates insulin control ofprotein synthesis, autophagy, mitochondrial function, and, through feedback signaling tophosphorylation of IRS1 at serine residues, mTOR directly controls insulin signaling. Weshow that in adipocytes from patients with type 2 diabetes (T2D) insulin activation of mTORis attenuated and that the resultant phenotype is compatible with, and can be mimicked by,loss of mTOR activation. In T2D adipocytes mitochondrial function is impaired andautophagy strongly upregulated, with concomitant increased autophagic destruction ofmitochondria and lipofuscin particles, and a dependence on autophagy for ATP production.Conversely, mitochondrial dysfunction attenuates insulin activation of mTOR, enhancesautophagy and attenuates feedback to IRS1. Our findings put mTOR in the driver´s seat of aninsulin resistance that in adipocytes can be fuelled by mitochondrial dysfunction,inflammation, ER-stress, or hypoxia.
Place, publisher, year, edition, pages
Feinstein Institute for Medical Research, 2010
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-20655 (URN)10.2119/molmed.2010.00023 (DOI)000280048100001 ()20386866 (PubMedID)
2009-09-162009-09-162023-03-03Bibliographically approved